Gvoke VialDx is expected to be available in the third quarter of 2025. The Food and Drug Administration (FDA) has approved Gvoke VialDx ™ (glucagon) for intravenous use as a diagnostic aid during ...
Uncover the latest and most impactful research in Gastrointestinal Motility and Reflux Disorders. Explore pioneering discoveries, insightful ideas and new methods from leading researchers in the field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results